Ludwig scientists around the world are continually making discoveries that alter our understanding of cancer. Our science is featured in the most prestigious journals and in general media. Explore some of our most recent findings, news and reports.
For media inquiries, contact
Vice President for Communications
Five Ludwig researchers named AACR fellows
April 02, 2014, New York, NY - Ludwig Cancer Research congratulates its eminent researchers Joan Brugge, Richard Hynes, Ken Kinzler, Richard Kolodner and Irving Weissman on their election this year as fellows of the American Association for Cancer Research (AACR). The AACR only recognizes as fellows those researchers who have made exceptional contributions to the understanding and treatment of cancer.
The fellows are selected following a rigorous peer review process, and we have little doubt that the Ludwig researchers honored this year passed such review with flying colors.
The Ludwig researchers inducted into the Academy hold the following posts:
- Joan Brugge is co-director of the Ludwig Center at Harvard
- Richard Hynes is a Ludwig professor at the Ludwig Center at MIT
- Kenneth Kinzler is co-director of the Ludwig Center at Johns Hopkins
- Richard Kolodner is a member of the Ludwig Institute for Cancer Research San Diego
- Irving Weissman is director of the Ludwig Center at Stanford
They will be inducted into the AACR Academy, along with other members of the 2014 class of AACR fellows, at the Association’s annual meeting in San Diego, Calif., April 5-9, and formally recognized during the opening plenary session of the meeting on Sunday, April 6. The researchers join their Ludwig colleagues who were elected to the first class of the Academy last year.
About Ludwig Cancer Research
Ludwig Cancer Research is an international collaborative network of acclaimed scientists with a 40-year legacy of pioneering cancer discoveries. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.